机译:使用无细胞表达的真核膜蛋白的选择性甲基标记
Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115, United States, Max-Planck Institute for Biophysical Chemistry, Am Fassberg 11, 37077 Goettingen, Germany;
Faculty of Chemistry and Pharmacy, Sofia University, Sofia 1164, Bulgaria, FB Reagents, Cambridge, Massachusetts 02139, United States;
Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115, United States, Institute for Advanced Study, Technische Universitaet Muenchen, 85748 Garching, Germany;
Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115, United States;
Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115, United States;
Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115, United States;
机译:基于前体的无细胞合成蛋白的选择性甲基标记
机译:膜蛋白的无细胞表达和稳定同位素标记策略
机译:膜蛋白的无细胞表达和稳定同位素标记策略
机译:一种无细胞表达系统的开发,以产生用于定量质谱法的稳定同位素标记的蛋白质标准
机译:流感病毒神经氨酸酶,一种氨基端锚定膜糖蛋白(唾液酸酶,真核生物,表达)的结构功能分析
机译:可选择的真核膜蛋白的甲基标记使用无细胞表达
机译:使用无细胞表达对真核细胞膜蛋白进行选择性甲基标记。
机译:(35s)甲硫氨酸标记细胞膜十二烷基硫酸钠 - 聚丙烯酰胺梯度凝胶电泳中小鼠淋巴母细胞瘤中膜蛋白的可变表达